Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2006 1
2008 1
2010 1
2011 2
2012 1
2013 1
2014 3
2015 1
2016 3
2017 1
2019 5
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group. Montalban X, et al. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.
The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study.
Drulovic J, Pekmezovic T, Tamas O, Adamec I, Aleksic D, Andabaka M, Basic Kes V, Butkovic Soldo S, Cukic M, Despinic L, Dincic E, Djelilovic Vranic J, Grgic S, Habek M, Hristova SI, Ivanovic J, Jovanovic A, Jovicevic V, Krbot Skoric M, Kuzmanovski I, Maric G, Mesaros S, Milanov IG, Miletic Drakulic S, Sinanovic O, Skarpa Prpic I, Sremec J, Tadic D, Toncev G, Sokic D. Drulovic J, et al. Among authors: toncev g. Front Immunol. 2023 Nov 7;14:1284031. doi: 10.3389/fimmu.2023.1284031. eCollection 2023. Front Immunol. 2023. PMID: 38022568 Free PMC article.
VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS.
Drulović J, Tončev G, Nadj Č, Obradović D, Eraković J, Mesaroš Š, Čukić M, Aleksić D, Andabaka M, Ivanović J, Jovanović A, Kostić M, Marić G, Marković A, Martinović V, Parojčić A, Perić S, Sakalaš L, Suknjaja V, Vesić K, Vojvodić S, Vuković T, Benedict RHB, Pekmezović T. Drulović J, et al. Among authors: toncev g. Acta Clin Croat. 2022 Mar;61(1):62-69. doi: 10.20471/acc.2022.61.01.08. Acta Clin Croat. 2022. PMID: 36398076 Free PMC article.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans.
Peric S, Milosevic V, Berisavac I, Stojiljkovic O, Beslac-Bumbasirevic L, Marjanovic I, Djuric V, Djordjevic G, Rajic S, Cvijanovic M, Babic M, Dominovic A, Vujovic B, Cukic M, Petrovic M, Toncev G, Komatina N, Martic V, Lavrnic D. Peric S, et al. Among authors: toncev g. J Peripher Nerv Syst. 2014 Dec;19(4):317-21. doi: 10.1111/jns.12096. J Peripher Nerv Syst. 2014. PMID: 25582576
25 results